Kepal N. Patel

Biosketch / Results /

Kepal N. Patel, M.D.

Associate Professor; Dir Division of Endocrine Surgery
Departments of Surgery (Endocrine Division), Biochemistry and Molecular Pharmacology and Otolaryngology (Otolaryngology)
NYU Endocrine Surgery Associates

Clinical Addresses

530 FIRST AVENUE, HCC 6H
SCHWARTZ EAST ELEVATORS
NEW YORK, NY 10016
Hours: Mon. 9 - 5; Tue. 9 - 5; Wed. 9 - 5; Thu. 9 - 5; Fri. 9 - 5
Handicap Access: yes
Phone: 212-263-7710
Fax: 212-263-2828

« Back to Results

Medical Specialties

Cancer, General Surgery

Medical Expertise

Head & Neck Surgery, Endocrine Surgery, Thyroid Surgery, Head & Neck Cancer, Parathyroid Surgery

Clinical Responsibilities

I am a surgeon who has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid tumors. My expertise extends to all head and neck tumors including cancers of the mouth, throat, voice box, parotid and other salivary glands, skin, melanoma, soft tissue, nerves and blood vessels of the neck.

Languages

Spanish

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AMERICAN IMAGING NETWORK, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, NY MEDICAID, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, TOUCHSTONE MEDICARE, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2003 — Ab Surgery - Surgery

Education

1996 — Robert Wood Johnson Medical School, Medical Education
1996-2002 — Robert Wood Johnson Univ. Hosp. (Surgery (General)), Residency Training
2002-2004 — Memorial Sloan-Kettering Cancer Center (Head & Neck), Clinical Fellowships

« Back to Results

Research Summary

The optimal management of thyroid cancer is dependent on the assessment of the malignant potential of the individual tumor at presentation. Understanding the genetic mechanisms controlling thyroid tumor progression can provide valuable prognostic markers and potential therapeutic targets. Our research focuses on the changes in intracellular molecular pathways that lead to the progression of thyroid cancer. When these pathways are understood, specific drugs can be developed to block these changes. By comparing genomic differences between different thyroid cancers, our laboratory has identified genes that may play a role in determining their behavior. Furthermore, we have identified molecular factors that potentially promote thyroid cancer metastases. We are developing new strategies to target the genes associated with aggressive thyroid cancer behavior. By understanding the biology of individual tumors, we will be able to create personalized cancer treatment plans for our patients. I have joint appointments in Surgery and Biochemistry, and have been recruited to lead the endocrine surgery research program.

Research Interests

Our laboratory has been interested in studying the molecular pathogenesis of thyroid carcinoma, specifically trying to identify molecular factors which can help predict thyroid tumor progression and potentially serve as therapeutic targets.